Leap Therapeutics (LPTX)
(Delayed Data from NSDQ)
$2.43 USD
+0.07 (2.97%)
Updated May 31, 2024 04:00 PM ET
After-Market: $2.40 -0.03 (-1.23%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum F VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 35% (88 out of 250)Zacks Sector Rank
Top 50% (8 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.25 | 1.35 | 9.99 |
Current Quarter Estimate | -0.42 | 7.43 | 57.00 |
Year Ago Quarter Estimate | -0.91 | 0.12 | 52.54 |
Next Quarter Estimate | -0.39 | 7.81 | 61.00 |
Next Year Estimate | -1.48 | 37.76 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 58.29 | 15.50 | 15.67 |
Next Year | 10.84 | 8.80 | 9.31 |
Last 5 Years | NA | 1.00 | 8.10 |
Next 5 Years | NA | 20.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.18 |
Price/Book (MRQ) | 1.31 | 2.20 |
Price/Cash Flow (MRFY) | NA | 16.72 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -167.94% |
Return on Equity (TTM) | -81.00% | -59.04% |
Debt to Equity (MRQ) | 0.00 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.